Point72 Hong Kong LTD Precision Biosciences Inc Transaction History

Point72 Hong Kong LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.15 - $3.34 $733 - $2,130	-638 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.96 - $7.76 $1,888 - $4,950	638 New	638 $2,000
Q4 2021 Feb 14, 2022	SELL	$7.4 - $11.66 $14,126 - $22,258	-1,909 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$9.18 - $14.15 $17,524 - $27,012	1,909 New	1,909 $22,000
Q2 2021 Aug 16, 2021	SELL	$8.07 - $12.52 $4,890 - $7,587	-606 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$8.57 - $15.79 $5,193 - $9,568	606 New	606 $6,000
Q3 2020 Nov 16, 2020	SELL	$4.65 - $8.73 $19,581 - $36,762	-4,211 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$4.66 - $8.7 $18,160 - $33,903	3,897 Added 1241.08%	4,211 $35,000
Q1 2020 May 15, 2020	BUY	$5.05 - $15.01 $1,585 - $4,713	314 New	314 $2,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $550M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.